DXCM vs IDAI · P/E 63, rev $2.50B vs rev $3.1M
DexCom Inc (DXCM) versus Trust Stamp Inc (IDAI) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Trust Stamp Inc (IDAI) is a software - application company listed on NASDAQ.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported IDAI revenue for 2025-12-31 was $3.1M. Net income was -$8.3M. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. IDAI currently screens at market cap $10.9M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. IDAI currently screens at market cap $10.9M.
Not investment advice. Open the DXCM and IDAI stock pages for the full models.
Not investment advice.